- When Is the Next Clinical Biochemical Genetics Exam?
- Why Biochemical Genetics Follows an Odd-Year Cycle
- What Is and Isn't Established About 2026
- Working Backward From August 2027
- Scheduling Study Around the Blueprint
- Which Domains to Schedule in Which Phase
- How to Verify Dates and Deadlines Yourself
- Why the Timing Matters for Your Career
- Frequently Asked Questions
- The next Clinical Biochemical Genetics certifying exam is August 2027; biochemical specialties are offered in odd-numbered years.
- ABMGG approved a move to an annual certifying exam schedule, so confirm future cycles directly on abmgg.org.
- The blueprint in effect is dated August 2025 and lists fifteen content categories, led by Amino acids at about 15%.
- Fee, question count, timer and passing score were not established from the official source reviewed, so check ABMGG before budgeting.
When Is the Next Clinical Biochemical Genetics Exam?
If you searched for 2026 testing windows, here is the direct answer: the next Clinical Biochemical Genetics (CBG) certifying exam is identified as August 2027. The American Board of Medical Genetics and Genomics (ABMGG), which issues this credential, has published a notice that its 2027 certification exams will take place August 11-14, 2027. Biochemical genetics is offered in odd-numbered years, which is why 2026 is not a sitting year for this specialty.
That can feel like an anticlimax if you were hoping to sit this year. In practice, it is useful information. A known date more than a year out lets you build a deliberate preparation plan rather than reacting to a registration deadline. This article explains how the schedule works, what has and has not been established, and how to organize the intervening months around the actual content of the exam.
Why Biochemical Genetics Follows an Odd-Year Cycle
ABMGG has historically offered its certifying examinations on a rotating basis across specialties. Biochemical specialties sit on the odd-year side of that rotation, which is what places the next CBG sitting in August 2027 rather than 2026. ABMGG has also publicly approved a transition toward an annual certifying examination schedule. The practical meaning of that change for biochemical genetics candidates depends on implementation details published by the Board, so treat the odd-year pattern as the confirmed baseline and the annual transition as something to monitor.
| Item | What the official sources establish |
|---|---|
| Certifying body | American Board of Medical Genetics and Genomics (ABMGG) |
| Next CBG exam | August 2027 (ABMGG 2027 exams announced for August 11-14, 2027) |
| Specialty cycle | Biochemical specialties offered in odd years |
| Schedule policy | ABMGG approved a transition to an annual certifying exam schedule |
| Current blueprint | Biochemical Genetics Blueprint and Content Codes, effective August 2025 |
| Fee, timer, question count, passing score | Not established from the supplied official source content; verify with ABMGG |
What Is and Isn't Established About 2026
Honest scheduling guidance requires separating confirmed facts from open questions. Here is where things stand.
Confirmed
- The next CBG sitting is August 2027, within the announced August 11-14, 2027 ABMGG exam window.
- The governing content document is the ABMGG Biochemical Genetics Blueprint effective August 2025, organized into fifteen categories.
- ABMGG has approved a shift to an annual certifying examination schedule.
Not established in the source material reviewed
- The examination fee, application fee structure and any late fees.
- The number of questions and the time allowed.
- The passing score or scoring method.
- Exact application opening and closing dates for the 2027 cycle.
One wrinkle worth knowing: the ABMGG content-outline index references 2026 outlines, while the biochemical blueprint document available is effective August 2025. Do not read that as a conflict about when you can test. It simply means ABMGG's website organizes its documents by posting cycle, and you should always download the blueprint currently linked from the Board's content outlines page before you finalize your study plan.
For cost planning, see CBG Certification Cost 2026, and for score expectations see CBG Passing Score 2026. Both pages are most useful when read alongside the current ABMGG fee schedule rather than instead of it.
Working Backward From August 2027
With the sitting more than a year away, the strongest move is to treat 2026 as a build year. A reasonable arc looks like this:
Confirm eligibility and gather the blueprint
- Review pathway and prerequisites on CBG Requirements 2026 and against ABMGG's own eligibility pages.
- Download the August 2025 Biochemical Genetics Blueprint and use its fifteen categories as your master checklist.
- Take an honest baseline on your weakest metabolic categories.
Deep content passes by category
- Work through the heavy categories first (Amino acids, Lipids, Organic acids, Lysosomes).
- Pair each disorder with its enzyme defect, key analytes, inheritance and treatment logic.
Application and integration
- Watch ABMGG for the application window and any registration instructions for the August sitting.
- Shift from category-by-category study to mixed case-style review.
Consolidation
- Revisit laboratory content, pattern recognition across analyte profiles and low-weight categories.
- Confirm logistics for the August 11-14 window well before test week.
Key Takeaway
Do not wait for the application to open before you start. The exam content spans fifteen categories of inborn errors of metabolism, and the long runway before August 2027 is where most of your actual score is built.
Scheduling Study Around the Blueprint
The official blueprint publishes approximate weights for each of its fifteen categories. They are preserved here exactly as supplied: Amino acids 15%, Organic acids 12%, Cofactors 7%, Carbohydrates 10%, Lipids 13%, Lysosomes 12%, Mitochondria 7%, Peroxisomes 3%, Purines and pyrimidines 3%, Transport 3%, Creatine 1%, Neurotransmitters 2%, Metals 3%, Laboratory 8%, and Other disease category 3%. These sum to 102% because of a discrepancy in the source total; they are approximate guides to emphasis, not an exact scoring formula.
Those weights should shape your calendar. Three categories alone (Amino acids, Lipids, Organic acids) account for roughly 40% of the stated emphasis, and adding Lysosomes and Carbohydrates brings the five largest categories to well over half. Yet low-weight categories are not safe to skip, since a rare disorder can still appear and the categories overlap in diagnostic reasoning. For a full walkthrough of what each category covers, see CBG Exam Domains 2026: Complete Guide to All 15 Content Areas.
Which Domains to Schedule in Which Phase
Rather than studying in blueprint order, sequence categories by how much they build on each other. Here is a CBG-specific way to allocate your calendar.
Phase 1: Core small-molecule metabolism (Amino acids, Organic acids)
These two categories together carry roughly a quarter of the exam's emphasis and teach the diagnostic grammar you will reuse everywhere else.
- Amino acids: PKU and hyperphenylalaninemia, tyrosinemias, glycine encephalopathy, MSUD and branched-chain disorders, homocystinuria and sulfur amino acid and re-methylation disorders, urea cycle defects, serine and related disorders.
- Organic acids: methylmalonic and propionic acidemia, 3-MCC and other C5OH-related disorders, IVA and C5-related disorders, glutaric acidemia type I, ketone body disorders (HMG-CoA lyase, SCOT), and others such as glutathione synthetase deficiency, ECHS1 and non-type 1 3-methylglutaconic aciduria.
Phase 2: Energy metabolism (Lipids, Carbohydrates, Mitochondria, Cofactors)
These categories share a common theme of fasting tolerance, energy failure and cofactor dependence, so they reinforce one another when studied close together.
- Lipids: fatty acid oxidation disorders (short-chain, medium-chain, long-chain, multiple acyl-CoA dehydrogenase deficiency/GA2), hyperlipidemias including Tangier disease, and cholesterol and bile acid disorders including Smith-Lemli-Opitz and Niemann-Pick C.
- Carbohydrates: glycogenoses (excluding GSD II, which is placed with lysosomal disorders), glycolysis and gluconeogenesis disorders, galactose and fructose metabolism, congenital disorders of glycosylation, and pentose phosphate pathway disorders.
- Mitochondria: myopathies with laboratory findings, Leigh syndrome, adult presentations, electron transport chain and assembly disorders, mtDNA mutation, maintenance and depletion disorders, and MELAS.
- Cofactors: cobalamin, biotin, molybdenum, folate, pyridoxine, biopterin, and others including riboflavin, niacin and thiamine.
Phase 3: Storage and organelle disorders (Lysosomes, Peroxisomes)
Lysosomal disease alone carries about 12% of the emphasis and rewards organized, table-based memorization of enzyme, substrate and phenotype.
- Mucopolysaccharidoses (Types I, II, III, IV, VI, VII), sphingolipidoses (Gaucher, Fabry, GM2 gangliosidoses including Tay-Sachs and Sandhoff, Krabbe, Niemann-Pick A and B, GM1), multiple enzyme deficiencies (ML-II, ML-III, multiple sulfatase deficiency), and others including Pompe, cystinosis and NCL.
- Peroxisomes: Zellweger-spectrum biogenesis disorders, X-linked adrenoleukodystrophy and other single-enzyme disorders, and conditions such as infantile Refsum.
Phase 4: Smaller categories and the laboratory
Purines and pyrimidines, Transport, Creatine, Neurotransmitters, Metals, and the Other disease category are individually small but collectively meaningful. The Laboratory category (about 8%) covers QA/QC, artifact recognition, techniques and regulations, and it is worth dedicated time because laboratory reasoning threads through case questions in every other category.
- Purines and pyrimidines: Lesch-Nyhan disease, adenosine deaminase deficiency, UMP synthase deficiency.
- Transport: cystinuria, lysinuric protein intolerance, glucose and carnitine transport.
- Neurotransmitters: SSADH deficiency, dopamine synthesis disorders, GABA metabolism.
- Metals: Wilson disease, Menkes disease, iron and zinc disorders.
How to Verify Dates and Deadlines Yourself
Because exam logistics can change, build a short verification routine instead of relying on any third-party summary, this one included.
- Bookmark the ABMGG initial certification pages. The content outlines and blueprints page and the news page announcing exam dates are the primary sources. The 2027 exam announcement and the annual-schedule approval notice are both published there.
- Re-download the blueprint periodically. The version in effect is dated August 2025. If ABMGG posts a revision before your sitting, your study checklist should follow the newer document.
- Watch for the application window. Deadlines, fee tables and any late-filing rules come from ABMGG's application materials, not from the blueprint. Record each date the moment it is published.
- Re-check after policy announcements. The approved transition to an annual schedule means timelines for all specialties may shift, so recheck the news page whenever you hear about changes.
- Plan logistics early. The announced window is August 11-14, 2027. Build in travel flexibility and confirm your specific test day assignment as soon as ABMGG provides it.
Why the Timing Matters for Your Career
Clinical biochemical geneticists work in settings that diagnose and manage inherited metabolic disease: academic medical centers, children's hospitals, metabolic clinics and clinical biochemical genetics laboratories, including reference labs that run amino acid, organic acid and enzyme assays. Because the exam content leans so heavily on interpreting analyte patterns and laboratory quality, the credential is closely tied to those roles. Timing your sitting well, ideally before a job search or promotion cycle rather than in the middle of one, helps avoid a gap where you are qualified in practice but not yet certified on paper.
Questions about what the credential does for compensation and hiring are covered in CBG Salary Guide 2026, Is the CBG Certification Worth It? and CBG Jobs. Those pages stay qualitative where figures are not firmly established, which is the right posture here as well. When you are ready to test your recall under realistic conditions, the practice questions on the main practice test site are a good complement to the blueprint itself.
Key Takeaway
Treat the blueprint as exam objectives, not a full curriculum. The categories tell you what is tested; they do not replace broader biochemical genetics references or hands-on laboratory experience. Use the long lead time before August 2027 to do both.
If you want to see how demanding the content is before committing to a calendar, read How Hard Is the CBG Exam? and CBG Pass Rate 2026: What the Data Shows, and then pressure-test your readiness with timed sets on the CBG Exam Prep practice platform.
Frequently Asked Questions
The next CBG certifying exam is identified as August 2027. ABMGG announced that its 2027 certification exams will take place August 11-14, 2027, and biochemical specialties are offered in odd-numbered years.
Based on the odd-year offering pattern for biochemical specialties, 2026 is not a sitting year for CBG. ABMGG has approved a move to an annual schedule, so check abmgg.org for how that change is implemented and whether it affects biochemical genetics.
The August 2025 blueprint lists fifteen categories, from Amino acids (about 15%), Lipids (about 13%), Organic acids and Lysosomes (about 12% each) and Carbohydrates (about 10%) to Laboratory (about 8%) and several small categories such as Creatine (about 1%). Percentages are approximate and total 102% in the source.
The fee, question count, timer and passing score were not established from the official source content reviewed for this article. Confirm all of them on the ABMGG website before you budget or plan your pacing strategy.
ABMGG's initial certification pages are the authoritative source. For an overview of how pathways typically work, see our CBG requirements guide, but always defer to the Board's current published rules and the dates it posts for the 2027 cycle.